| Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426) |
|---|
| 04/26/2007 | US20070093458 Preparation of paricalcitol and crystalline forms thereof |
| 04/25/2007 | CN1953752A Treatment of interstitial cystitis with vitamin D compounds |
| 04/24/2007 | US7208484 Osteoporosis; skin disorders; condensation bicyclic ketone with allylic phosphine |
| 04/19/2007 | US20070088008 treating psoriasis with e.g. 19-nor-2beta-ethyl-1alpha,25-dihydroxyvitamin D3 |
| 04/19/2007 | US20070088007 Method for preparing analogue of vitamin D |
| 04/19/2007 | DE102006047173A1 Verfahren zur Herstellung eines Analogons von Vitamin D Process for the preparation of an analogue of vitamin D |
| 04/18/2007 | EP1436257B1 Low-calcemic oxime analogs of 1alpha, 25-dihydroxy vitamin d3 |
| 04/18/2007 | EP1305030B1 Use of 2-alpha-methyl-19-nor-20(s)-1-alpha,25-dihydroxyvitamin d3 in bone replacement |
| 04/18/2007 | CN1948283A Preparation method of vitamin D derivative |
| 04/17/2007 | US7205420 Forming calcipotriol |
| 04/17/2007 | US7205286 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 04/12/2007 | WO2007011951A3 Purification of paricalcitol |
| 04/05/2007 | WO2007038094A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3 |
| 04/05/2007 | WO2006119309A3 19,26,27-TRINOR-1α,25-DIHYDROXYVITAMIN D3 COMPOUNDS |
| 04/05/2007 | CA2623481A1 19,23,24,25,26,27-hexanor-1alpha-hydroxyvitamin d3 |
| 04/04/2007 | EP1768988A1 Novel phenyl-boronic acid derivatives and methods for the preparation thereof |
| 04/03/2007 | CA2205275C Vitamin d3 analogs |
| 03/28/2007 | CN1938268A Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues |
| 03/28/2007 | CN1307154C Method for photochemosynthesis of vitamin D2 |
| 03/22/2007 | US20070066566 19,23,24,25,26,27-Hexanor-1alpha-hydroxyvitamin D3 |
| 03/21/2007 | CN1934078A Stereoselective synthesis of vitamin D analogues |
| 03/08/2007 | WO2007028000A2 Des-c,d analogs of 1alpha,25-dihydroxy-19-norvitamin d3 |
| 03/08/2007 | US20070054887 Benign prostatic hyperplasia, hyptertrophy, overactivity; giving vitamin D receptor agonists: calcitrol, 1-a-fluoro-25-hydroxy-16,23-diene-26,27-bishomo-20-epi-cholecalciferol, 1,25-dihydroxy-16-ene-23-yne cholecalciferol, 1,3-di-O-acetyl-1,25-dihydroxy-16,23-diene-26,27-hexafluoro-19-nor-cholecalciferol |
| 02/28/2007 | EP1756048A2 Process and intermediates to prepare the sulphonyl derivatives of cholecalciferol |
| 02/28/2007 | EP1482951B8 1-alpha-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| 02/22/2007 | WO2006113990A3 LOW-CALCEMIC 16,23-DIENE 25-OXIME ANALOGS OF 1α ,25-DIHYDROXY VITAMIN D3 |
| 02/22/2007 | CA2619311A1 Synthesis of 1.alpha.-fluoro-25-hydroxy-16-23e-diene-26,27-bishomo-20-epi-cholecalciferol |
| 02/08/2007 | US20070032461 1,3 Aclyated 24-keto-vitamin d3 compounds and methods of use thereof |
| 02/01/2007 | US20070027333 Stereoselective synthesis of vitamin d analogues |
| 01/25/2007 | CA2612604A1 Purification of paricalcitol |
| 01/24/2007 | EP1745787A2 Non-calcemic, antiproliferative, transcriptionally active sulfur-containing analogs of 1-alpha 25-dihydroxy Vitamin D3 |
| 01/23/2007 | US7166585 24-Sulfur-substituted analogs of 1α,25-dihydroxy vitamin D3 |
| 01/18/2007 | US20070015931 Novel phenylboronic acid compounds and intermediates and processes for the preparation thereof |
| 01/04/2007 | WO2006039685A3 Methods for synthesis of chiral intermediates of carotenoids, carotenoid analogs, and carotenoid derivatives |
| 01/03/2007 | EP1737468A2 Treatment of interstitial cystitis with vitamin d compounds |
| 01/03/2007 | EP1641466B1 2-methylene-19-nor-20(s)-25-methyl-1alpha-hydroxycalciferol and its uses |
| 01/03/2007 | EP1103300B1 Ultraviolet irradiation apparatus for photochemical reaction and method for preparing vitamin d derivative using the same |
| 12/28/2006 | US20060293291 bone formation is desired, such as osteoporosis, as well as autoimmune diseases such as multiple sclerosis, diabetes mellitus and lupus; exhibit pronounced activity in arresting the proliferation of undifferentiated cells; 2-[(3'-methoxymethoxy)propylidene]-19-nor-1 alpha ,25-(OH)2,D3 |
| 12/27/2006 | EP1735277A1 2-alkylidene-18,19-dinor-vitamin d compounds |
| 12/27/2006 | EP1735276A2 Novel method for the preparation of intermediates useful for the synthesis of vitamin d analogues |
| 12/27/2006 | CN1886140A Methods for treating bladder dysfunction |
| 12/21/2006 | WO2006094064A3 Method of reducing scars with vitamin d |
| 12/13/2006 | EP1730108A1 Stereoselective synthesis of vitamin d analogues |
| 12/07/2006 | US20060275880 Selective enzymatic esterfication and solvolysis of epimeric vitamin D analog and separation and epimerization of the epimers |
| 12/06/2006 | EP0948334B1 Method of treating prostatic diseases using active vitamin d analogues |
| 12/05/2006 | CA2146429C 25-carboxylic acid derivatives in the vitamin d series, method of producing them, intermediate products for this method, pharmaceutical preparations containing these derivatives and their use in the manufacture of medicines |
| 11/29/2006 | EP1490332B1 Method of synthesizing 1-alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol |
| 11/28/2006 | US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds |
| 11/23/2006 | US20060264410 useful in treating biological disorders mediated by vitamin D receptors and/or in treating disorders where a rise in serum calcium is undesirable |
| 11/22/2006 | CN1285573C 3-desoxy-vitamin D3 analog esters |
| 11/21/2006 | CA2204478C Fluorinated vitamin d3 analogs |
| 11/16/2006 | WO2006074226A3 Prevention of thrombotic disorders with active vitamin d compounds or mimics thereof |
| 11/16/2006 | US20060258630 Method for the prevention and treatment of uveitis |
| 11/09/2006 | WO2006119309A2 19,26,27-TRINOR-1α,25-DIHYDROXYVITAMIN D3 COMPOUNDS |
| 11/09/2006 | WO2006086613A3 2-METHYLENE-19-NOR- (20S-24S) - 1α, 25-D IHYDROXYVITAMIN-D2 |
| 11/09/2006 | CA2605727A1 19,26,27-trinor-1.alpha.,25-dihydroxyvitamin d3 compounds |
| 11/02/2006 | WO2006116204A1 Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin d compounds or mimics thereof |
| 11/02/2006 | US20060247453 Enzymatic transformation of a prostaglandin (bimatoprost) intermediate |
| 11/02/2006 | EP1180035B1 NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1-alpha, 25-DIHYDROXY VITAMIN D3 |
| 11/02/2006 | CA2606517A1 Treatment, prevention and amelioration of pulmonary disorders associated with chemotherapy or radiotherapy with active vitamin d compounds or mimics thereof |
| 11/02/2006 | CA2605815A1 Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3 |
| 10/24/2006 | CA2205315C Fluorinated vitamin d3 analogs |
| 10/19/2006 | WO2006036892A3 Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| 10/19/2006 | DE102005017775A1 New complex of vitamin-D-compounds with 5Z,7E,10(19)-triene system and methylene derivatives of beta-cyclodextrin, useful for the preparation of medicament and to treat psoriasis |
| 10/17/2006 | US7122530 24-hydroxyvitamin D, analogs and uses thereof |
| 10/05/2006 | WO2006105221A1 2-METHYLENE-19-NOR-(23S)-25-DEHYDRO-1α-HYDROXYVITAMIN D3-26,23-LACTONE AND 2-METHYLENE-19-NOR-(23R)-25-DEHYDRO-1α-HYDROXYVITAMIN D3-26,23-LACTONE |
| 10/05/2006 | WO2006057914A3 2-methylene-19-nor-(20s)-1alpha-hydroxy-trishomopregnacalciferol |
| 10/05/2006 | WO2006057913A3 2-METHYLENE-19-NOR-(20R)-1-α-HYDROXY-BISHOMOPREGNACALCIFEROL |
| 10/05/2006 | WO2006057884A3 2α-METHYL AND 2ß-METHYL ANALOGS OF 19,26,27-TRINOR-(20S)-1α-HYDROXYVITAMIN D3 AND THEIR USES |
| 10/05/2006 | DE19744127B4 Neue Vitamin D-Derivate mit Cyclopropylringen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung sowie ihre Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with Cyclopropylringen in the side chains, processes and intermediates for their preparation and their use for the production of pharmaceuticals |
| 10/05/2006 | CA2603328A1 2-methylene-19-nor-(23s)-25-dehydro-1.alpha.-hydroxyvitamin d3-26,23-lactone and 2-methylene-19-nor-(23r)-25-dehydro-1.alpha.-hydroxyvitamin d3-26,23-lactone |
| 10/04/2006 | EP1482951B1 Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 10/04/2006 | CN1277817C Method for synthesizing 1 alpha-hydroxy-2-methylene-19-nor- vitamin d compounds |
| 10/04/2006 | CN1277543C Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses |
| 10/03/2006 | US7115758 Vitamin D derivatives with cyclic substructures in the side chains, process and intermediate products for their production, and the use for the production of pharmaceutical agents |
| 10/03/2006 | US7115594 Administering to a patient with metabolic bone disease an effective amount of 2-methylene-19-nor-20(S)-1 alpha ,25-dihydroxyvitamin D3 compound to treat osteoporosis |
| 09/28/2006 | WO2006102647A1 20-alkyl, gemini vitamin d3 compounds and methods of use thereof |
| 09/28/2006 | WO2006074227A3 HIGHLY ANTIPROLIFERATIVE, LOW-CALCEMIC, ANALOGS OF THE HORMONE 1α, 25-DIHYDROXYVITAMIN D3 WITH CARBONYL SIDE CHAINS |
| 09/28/2006 | US20060217354 recrystallizing a crude or preliminarily purified product of vitamin D derivative from an alcohol, such as methanol |
| 09/28/2006 | US20060217353 24-sulfoximine vitamin D3 compounds |
| 09/28/2006 | CA2601914A1 20-alkyl, gemini vitamin d3 compounds and methods of use thereof |
| 09/27/2006 | CN1276927C Crystals of a vitamin D derivative and a method for the preparation thereof |
| 09/26/2006 | US7112579 26,27-Homologated-20-EPI-2-alkyl-19-nor-vitamin D compounds |
| 09/21/2006 | WO2006037023A3 Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| 09/21/2006 | US20060211661 24 hydroxyvitamin d, analogs and uses thereof |
| 09/13/2006 | CN1830941A Compound having hydroxycarbonyl-halogenoalkyl side chain |
| 09/08/2006 | WO2006093291A1 19-norvitamin d derivative |
| 09/08/2006 | WO2006093290A1 9-substituted-19-norvitamin d derivative |
| 09/05/2006 | US7101865 24-sulfoximine vitamin D3 compounds |
| 08/31/2006 | WO2006071129B1 Process for preparation of a pharmaceutical grade calcipotriol anhydrous |
| 08/24/2006 | US20060189576 Substituted vitamin d analogues and their therapeutic uses |
| 08/23/2006 | EP1693363A2 Crystals of a vitamin D derivative and a method for the preparation thereof |
| 08/22/2006 | US7094916 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 08/22/2006 | US7094776 cyclohexane ring is 3,5-dihydroxy-substituted and 2,4-alkylene-bridged; treating metabolic bone disease including senile, postmenopausal, and steroid-induced osteoporosis, osteomalacia, renal osteodystrophy and rickets |
| 08/22/2006 | US7094775 Method of treating breast cancer using a combination of vitamin D analogues and other agents |
| 08/22/2006 | US7094774 26,27-homologated-20-epi-2-alkylidene-19-nor-vitamin D compounds |
| 08/17/2006 | WO2006086613A2 2-METHYLENE-19-NOR- (20S-24S) - 1α, 25-D IHYDROXYVITAMIN-D2 |
| 08/17/2006 | WO2006086608A1 2-METHYLENE-19-NOR-(20S-24EPI)-1α,25-DIHYDROXYVITAMIN-D2 |
| 08/17/2006 | US20060183947 Stereoselectively reducing 2,6,6-trimethyl-2-cyclohexene-1,4-dione with an optically active chiral catalyst to form an optically active hydroxycyclohexenone, contacting the product with a reducing agent to form an optically active diol, and using the diol to form astaxanthin |
| 08/17/2006 | US20060183721 2-Methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin D2 |